Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib

<table>Overall survival in all enrolled patients. Median overall survival time was 11 months.</table>

Gastroenterology Research and Practice

Figure 2: Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib 